Loading…

β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes

Phosphorylated tau (pTau), total tau (tTau), and β-amyloid (Aβ) are established cerebrospinal fluid (CSF) biomarkers used to help diagnose Alzheimer disease. Preanalytic workups of CSF samples lack harmonization, making interlaboratory comparison of these biomarkers challenging. The Aβ adsorbs to sa...

Full description

Saved in:
Bibliographic Details
Published in:The journal of applied laboratory medicine 2021-09, Vol.6 (5), p.1155-1164
Main Authors: Strand, Heidi, Garabet, Lamya, Bjelke, Börje, Sithiravel, Cindhya, Hardang, Ingrid Marie, Moe, Morten K
Format: Article
Language:eng ; nor
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533
cites cdi_FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533
container_end_page 1164
container_issue 5
container_start_page 1155
container_title The journal of applied laboratory medicine
container_volume 6
creator Strand, Heidi
Garabet, Lamya
Bjelke, Börje
Sithiravel, Cindhya
Hardang, Ingrid Marie
Moe, Morten K
description Phosphorylated tau (pTau), total tau (tTau), and β-amyloid (Aβ) are established cerebrospinal fluid (CSF) biomarkers used to help diagnose Alzheimer disease. Preanalytic workups of CSF samples lack harmonization, making interlaboratory comparison of these biomarkers challenging. The Aβ adsorbs to sample tubes, yielding underestimated concentrations, and may result in false Alzheimer disease diagnosis. Our primary aim was to compare Aβ recovery across multiple polypropylene tubes and to test the stability of tTau, pTau, and Aβ in the best performing tube. Eight polypropylene tubes were tested using 3 CSF pools with Aβ concentrations 1000 ng/L. All samples were analyzed in duplicate. Tubes were cut open to assess their different infrared adsorption spectra. Freshly drawn CSF from 14 patients was distributed into 4 Sarstedt 5-mL (no. 63.504.027; Sar5CSF) tubes, left at room temperature for up to 7 days, and analyzed for pTau, tTau, and Aβ by ELISA. Two Sarstedt 5-mL tubes and a Sarstedt 10-mL (Sar10CSF) tube showed significantly higher Aβ recovery at all 3 concentrations compared with the 5 other tubes. The infrared adsorption spectra of Sar10CSF and Sar5CSF tubes were practically identical, unlike the other tubes. No significant loss of pTau, tTau, and Aβ was observed in CSF left at room temperature for up to 7 days (P > 0.05). Recovery of Aβ from Sar5CSF tubes is equivalent to Aβ recovery from Sar10CSF tubes. Levels of pTau, tTau, and Aβ were stable for at least 7 days at room temperature but not at 37 °C.
doi_str_mv 10.1093/jalm/jfab024
format article
fullrecord <record><control><sourceid>proquest_crist</sourceid><recordid>TN_cdi_cristin_nora_10852_92585</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2535833688</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533</originalsourceid><addsrcrecordid>eNo90c9O3DAQBnALURUE3HoGH0FqwH8yTsINraAgUFup9GzZyQR568RbOxHaPkIfhwfpM2Fg6ckzo58-yfoI-cTZKWeNPFsaP5wte2OZKLfIrigrKCpR8u08Q6WKpgS1Qw5SWjLGeC2Ukuwj2ZElg6au1C75---puBjWPriOupEuMKKNIa3caDy98rPrzul1eKRToLeIK3oz5Wswkxsf6PHXMNEfk2t_5e2E2nVezNiZ2Lk_WYSRhp5-j2hy1jqzPIcWU8JEM6OL4D22r-5-tpj2yYfe-IQHm3eP_Ly6vF9cF3ffvtwsLu6KVoKcCt4Bs8D7SjWAEjgTXJheWlMiWlQtdCiF7RvJDEfgHBRywY3Mpmo7kHKPHL3lttGl_BE9hmg0ZzUI3QioIYvjN7GK4feMadKDSy16b0YMc9ICJNRSqrrO9PN7WEgpYq9X0Q0mrnOgfqlIv1SkNxVlfrhJnu2A3X_8Xoh8BpUGjg0</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2535833688</pqid></control><display><type>article</type><title>β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes</title><source>Oxford University Press Journals</source><source>NORA - Norwegian Open Research Archives</source><creator>Strand, Heidi ; Garabet, Lamya ; Bjelke, Börje ; Sithiravel, Cindhya ; Hardang, Ingrid Marie ; Moe, Morten K</creator><creatorcontrib>Strand, Heidi ; Garabet, Lamya ; Bjelke, Börje ; Sithiravel, Cindhya ; Hardang, Ingrid Marie ; Moe, Morten K</creatorcontrib><description>Phosphorylated tau (pTau), total tau (tTau), and β-amyloid (Aβ) are established cerebrospinal fluid (CSF) biomarkers used to help diagnose Alzheimer disease. Preanalytic workups of CSF samples lack harmonization, making interlaboratory comparison of these biomarkers challenging. The Aβ adsorbs to sample tubes, yielding underestimated concentrations, and may result in false Alzheimer disease diagnosis. Our primary aim was to compare Aβ recovery across multiple polypropylene tubes and to test the stability of tTau, pTau, and Aβ in the best performing tube. Eight polypropylene tubes were tested using 3 CSF pools with Aβ concentrations &lt;500, 500-1000, and &gt;1000 ng/L. All samples were analyzed in duplicate. Tubes were cut open to assess their different infrared adsorption spectra. Freshly drawn CSF from 14 patients was distributed into 4 Sarstedt 5-mL (no. 63.504.027; Sar5CSF) tubes, left at room temperature for up to 7 days, and analyzed for pTau, tTau, and Aβ by ELISA. Two Sarstedt 5-mL tubes and a Sarstedt 10-mL (Sar10CSF) tube showed significantly higher Aβ recovery at all 3 concentrations compared with the 5 other tubes. The infrared adsorption spectra of Sar10CSF and Sar5CSF tubes were practically identical, unlike the other tubes. No significant loss of pTau, tTau, and Aβ was observed in CSF left at room temperature for up to 7 days (P &gt; 0.05). Recovery of Aβ from Sar5CSF tubes is equivalent to Aβ recovery from Sar10CSF tubes. Levels of pTau, tTau, and Aβ were stable for at least 7 days at room temperature but not at 37 °C.</description><identifier>ISSN: 2576-9456</identifier><identifier>EISSN: 2475-7241</identifier><identifier>DOI: 10.1093/jalm/jfab024</identifier><identifier>PMID: 34059876</identifier><language>eng ; nor</language><publisher>England</publisher><subject>Alzheimer Disease - diagnosis ; Amyloid beta-Peptides - cerebrospinal fluid ; Biomarkers ; Enzyme-Linked Immunosorbent Assay ; Humans ; Reference Standards</subject><ispartof>The journal of applied laboratory medicine, 2021-09, Vol.6 (5), p.1155-1164</ispartof><rights>American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.</rights><rights>info:eu-repo/semantics/openAccess</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533</citedby><cites>FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,315,786,790,891,26600,27957,27958</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34059876$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Strand, Heidi</creatorcontrib><creatorcontrib>Garabet, Lamya</creatorcontrib><creatorcontrib>Bjelke, Börje</creatorcontrib><creatorcontrib>Sithiravel, Cindhya</creatorcontrib><creatorcontrib>Hardang, Ingrid Marie</creatorcontrib><creatorcontrib>Moe, Morten K</creatorcontrib><title>β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes</title><title>The journal of applied laboratory medicine</title><addtitle>J Appl Lab Med</addtitle><description>Phosphorylated tau (pTau), total tau (tTau), and β-amyloid (Aβ) are established cerebrospinal fluid (CSF) biomarkers used to help diagnose Alzheimer disease. Preanalytic workups of CSF samples lack harmonization, making interlaboratory comparison of these biomarkers challenging. The Aβ adsorbs to sample tubes, yielding underestimated concentrations, and may result in false Alzheimer disease diagnosis. Our primary aim was to compare Aβ recovery across multiple polypropylene tubes and to test the stability of tTau, pTau, and Aβ in the best performing tube. Eight polypropylene tubes were tested using 3 CSF pools with Aβ concentrations &lt;500, 500-1000, and &gt;1000 ng/L. All samples were analyzed in duplicate. Tubes were cut open to assess their different infrared adsorption spectra. Freshly drawn CSF from 14 patients was distributed into 4 Sarstedt 5-mL (no. 63.504.027; Sar5CSF) tubes, left at room temperature for up to 7 days, and analyzed for pTau, tTau, and Aβ by ELISA. Two Sarstedt 5-mL tubes and a Sarstedt 10-mL (Sar10CSF) tube showed significantly higher Aβ recovery at all 3 concentrations compared with the 5 other tubes. The infrared adsorption spectra of Sar10CSF and Sar5CSF tubes were practically identical, unlike the other tubes. No significant loss of pTau, tTau, and Aβ was observed in CSF left at room temperature for up to 7 days (P &gt; 0.05). Recovery of Aβ from Sar5CSF tubes is equivalent to Aβ recovery from Sar10CSF tubes. Levels of pTau, tTau, and Aβ were stable for at least 7 days at room temperature but not at 37 °C.</description><subject>Alzheimer Disease - diagnosis</subject><subject>Amyloid beta-Peptides - cerebrospinal fluid</subject><subject>Biomarkers</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Humans</subject><subject>Reference Standards</subject><issn>2576-9456</issn><issn>2475-7241</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>3HK</sourceid><recordid>eNo90c9O3DAQBnALURUE3HoGH0FqwH8yTsINraAgUFup9GzZyQR568RbOxHaPkIfhwfpM2Fg6ckzo58-yfoI-cTZKWeNPFsaP5wte2OZKLfIrigrKCpR8u08Q6WKpgS1Qw5SWjLGeC2Ukuwj2ZElg6au1C75---puBjWPriOupEuMKKNIa3caDy98rPrzul1eKRToLeIK3oz5Wswkxsf6PHXMNEfk2t_5e2E2nVezNiZ2Lk_WYSRhp5-j2hy1jqzPIcWU8JEM6OL4D22r-5-tpj2yYfe-IQHm3eP_Ly6vF9cF3ffvtwsLu6KVoKcCt4Bs8D7SjWAEjgTXJheWlMiWlQtdCiF7RvJDEfgHBRywY3Mpmo7kHKPHL3lttGl_BE9hmg0ZzUI3QioIYvjN7GK4feMadKDSy16b0YMc9ICJNRSqrrO9PN7WEgpYq9X0Q0mrnOgfqlIv1SkNxVlfrhJnu2A3X_8Xoh8BpUGjg0</recordid><startdate>20210901</startdate><enddate>20210901</enddate><creator>Strand, Heidi</creator><creator>Garabet, Lamya</creator><creator>Bjelke, Börje</creator><creator>Sithiravel, Cindhya</creator><creator>Hardang, Ingrid Marie</creator><creator>Moe, Morten K</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>3HK</scope></search><sort><creationdate>20210901</creationdate><title>β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes</title><author>Strand, Heidi ; Garabet, Lamya ; Bjelke, Börje ; Sithiravel, Cindhya ; Hardang, Ingrid Marie ; Moe, Morten K</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng ; nor</language><creationdate>2021</creationdate><topic>Alzheimer Disease - diagnosis</topic><topic>Amyloid beta-Peptides - cerebrospinal fluid</topic><topic>Biomarkers</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Humans</topic><topic>Reference Standards</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Strand, Heidi</creatorcontrib><creatorcontrib>Garabet, Lamya</creatorcontrib><creatorcontrib>Bjelke, Börje</creatorcontrib><creatorcontrib>Sithiravel, Cindhya</creatorcontrib><creatorcontrib>Hardang, Ingrid Marie</creatorcontrib><creatorcontrib>Moe, Morten K</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>NORA - Norwegian Open Research Archives</collection><jtitle>The journal of applied laboratory medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Strand, Heidi</au><au>Garabet, Lamya</au><au>Bjelke, Börje</au><au>Sithiravel, Cindhya</au><au>Hardang, Ingrid Marie</au><au>Moe, Morten K</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes</atitle><jtitle>The journal of applied laboratory medicine</jtitle><addtitle>J Appl Lab Med</addtitle><date>2021-09-01</date><risdate>2021</risdate><volume>6</volume><issue>5</issue><spage>1155</spage><epage>1164</epage><pages>1155-1164</pages><issn>2576-9456</issn><eissn>2475-7241</eissn><notes>ObjectType-Article-1</notes><notes>SourceType-Scholarly Journals-1</notes><notes>ObjectType-Feature-2</notes><notes>content type line 23</notes><abstract>Phosphorylated tau (pTau), total tau (tTau), and β-amyloid (Aβ) are established cerebrospinal fluid (CSF) biomarkers used to help diagnose Alzheimer disease. Preanalytic workups of CSF samples lack harmonization, making interlaboratory comparison of these biomarkers challenging. The Aβ adsorbs to sample tubes, yielding underestimated concentrations, and may result in false Alzheimer disease diagnosis. Our primary aim was to compare Aβ recovery across multiple polypropylene tubes and to test the stability of tTau, pTau, and Aβ in the best performing tube. Eight polypropylene tubes were tested using 3 CSF pools with Aβ concentrations &lt;500, 500-1000, and &gt;1000 ng/L. All samples were analyzed in duplicate. Tubes were cut open to assess their different infrared adsorption spectra. Freshly drawn CSF from 14 patients was distributed into 4 Sarstedt 5-mL (no. 63.504.027; Sar5CSF) tubes, left at room temperature for up to 7 days, and analyzed for pTau, tTau, and Aβ by ELISA. Two Sarstedt 5-mL tubes and a Sarstedt 10-mL (Sar10CSF) tube showed significantly higher Aβ recovery at all 3 concentrations compared with the 5 other tubes. The infrared adsorption spectra of Sar10CSF and Sar5CSF tubes were practically identical, unlike the other tubes. No significant loss of pTau, tTau, and Aβ was observed in CSF left at room temperature for up to 7 days (P &gt; 0.05). Recovery of Aβ from Sar5CSF tubes is equivalent to Aβ recovery from Sar10CSF tubes. Levels of pTau, tTau, and Aβ were stable for at least 7 days at room temperature but not at 37 °C.</abstract><cop>England</cop><pmid>34059876</pmid><doi>10.1093/jalm/jfab024</doi><tpages>10</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2576-9456
ispartof The journal of applied laboratory medicine, 2021-09, Vol.6 (5), p.1155-1164
issn 2576-9456
2475-7241
language eng ; nor
recordid cdi_cristin_nora_10852_92585
source Oxford University Press Journals; NORA - Norwegian Open Research Archives
subjects Alzheimer Disease - diagnosis
Amyloid beta-Peptides - cerebrospinal fluid
Biomarkers
Enzyme-Linked Immunosorbent Assay
Humans
Reference Standards
title β-Amyloid in Cerebrospinal Fluid: How to Keep It Floating (Not Sticking) by Standardization of Preanalytic Processes and Collection Tubes
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-09-22T21%3A18%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_crist&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=%CE%B2-Amyloid%20in%20Cerebrospinal%20Fluid:%20How%20to%20Keep%20It%20Floating%20(Not%20Sticking)%20by%20Standardization%20of%20Preanalytic%20Processes%20and%20Collection%20Tubes&rft.jtitle=The%20journal%20of%20applied%20laboratory%20medicine&rft.au=Strand,%20Heidi&rft.date=2021-09-01&rft.volume=6&rft.issue=5&rft.spage=1155&rft.epage=1164&rft.pages=1155-1164&rft.issn=2576-9456&rft.eissn=2475-7241&rft_id=info:doi/10.1093/jalm/jfab024&rft_dat=%3Cproquest_crist%3E2535833688%3C/proquest_crist%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-1d50b51f7695e3510212af3ba4eebe6c5de32bf930a1e51156e121a3af37cd533%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2535833688&rft_id=info:pmid/34059876&rfr_iscdi=true